Connect your AI

Staar Surgical STAA Gain (Loss), Foreign Currency Transaction, before Tax

Gain (Loss), Foreign Currency Transaction, before Tax at other companies

Bausch Health CompaniesBHC

——

Bausch + LombBLCO

——

Other financials

Income statement

Revenue$93.5M+120%

Gross profit$68.9M+146%

Operating income$8.0M+114%

Net income$5.2M+110%

EPS (diluted)$0.10+109%

Balance sheet

Cash & equivalents$131.9M-23.8%

Total debt$37.3M+1.7%

Total equity$352.4M+0.7%

Total assets$451.1M-1.4%

Cash flow

Operating cash flow-$21.7M-278%

CapEx$443.0K-69.8%

Free cash flow-$22.1M-207%

Valuation

Market cap$1.44B+47.4%

Enterprise value$1.35B+61.6%

P/S5×+1.5×

Profitability

Gross margin76.9%+2.9pp

Operating margin-9.1%-3.5pp

Net margin-7.2%-3.0pp

FCF margin-19.6%+55.9pp

Returns & leverage

Return on equity-6%-2.4pp

Debt / equity0.1×0.0×

Current ratio5.1×+0.3×

Where this comes from

Reported directly by Staar Surgical in its filing.

Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossBeforeTax.

The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's gain (loss), foreign currency transaction, before tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Staar Surgical's gain (loss), foreign currency transaction, before tax?: Staar Surgical (STAA) reported gain (loss), foreign currency transaction, before tax of -$1.11M in Q1 2026.
How has Staar Surgical's gain (loss), foreign currency transaction, before tax changed year-over-year?: Staar Surgical's gain (loss), foreign currency transaction, before tax decreased by 178.3% year-over-year, from $1.42M to -$1.11M.